Dr Ameet Bakhai

• Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses results from the sirolimus-eluting balloon expandable stent in the treatment of patients with de novo native coronary artery lesions (SIRIUS) Trial, DJ Cohen, A Bakhai, C Shi, L Githiora, T Lavelle, RH Berezin, MB Leon, Circulation 110 (5), 508-514
• Beyond Restenosis Five-Year Clinical Outcomes From Second-Generation Coronary Stent Trials, DE Cutlip, AG Chhabra, DS Baim, MS Chauhan, S Marulkar, J Massaro, Circulation 110 (10), 1226-1230
• Drug-eluting stents: an early systematic review to inform policy, RA Hill, Y Dündar, A Bakhai, R Dickson, T Walley, European heart journal 25 (11), 902-919
• Can we afford to eliminate restenosis? Can we afford not to? D Greenberg, A Bakhai, DJ Cohen, Journal of the American College of Cardiology 43 (4), 513-518
• Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary interventionresults from the REPLACE-2 trial, DJ Cohen, AM Lincoff, TA Lavelle, HL Chen, A Bakhai, RH Berezin, Journal of the American College of Cardiology 44 (9), 1792-1800
• Coronary artery stents: a rapid systematic review and economic evaluation, R Hill, A Bagust, A Bakhai, R Dickson, Y Dündar, A Haycox, RM Mota, NIHR Evaluation, Trials and Studies Coordinating Centre (UK)
• Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes, RK Riezebos, E Ronner, E Ter Bals, T Slagboom, PC Smits, JM ten Berg, Heart 95 (10), 807-812
• Cost Effectiveness of Paclitaxel-Eluting Stents for Patients Undergoing Percutaneous Coronary RevascularizationResults From the TAXUS-IV Trial, A Bakhai, GW Stone, E Mahoney, TA Lavelle, C Shi, RH Berezin, Journal of the American College of Cardiology 48 (2), 253-261
• Conducting economic evaluations alongside multinational clinical trials: toward a research consensus, SD Reed, KJ Anstrom, A Bakhai, AH Briggs, RM Califf, DJ Cohen, American heart journal 149 (3), 434-443
• Clinical trials: A practical guide to design, analysis, and reporting, Remedica
• Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression, D Wang, W Zhang, A Bakhai, Statistics in medicine 23 (22), 3451-3467
• Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial, MJ Sculpher, G Lozano-Ortega, J Sambrook, S Palmer, O Ormanidhi, American heart journal 157 (5), 845-852
• Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes, A Bakhai, RA Hill, Y Dundar, R Dickson, T Walley, Cochrane Database Syst Rev 1
• The burden of coronary, cerebrovascular and peripheral arterial disease, A Bakhai, Pharmacoeconomics 22 (4), 11-18
• Mortality following non-ST elevation acute coronary syndrome: 4 years follow-up of the PRAIS UK Registry (Prospective Registry of Acute Ischaemic Syndromes in the UK), AK Taneja, J Collinson, MD Flather, A Bakhai, DP de Arenaza, D Wang, European heart journal 25 (22), 2013-2018
• The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study, A Lamy, B Jönsson, WS Weintraub, F Zhao, S Chrolavicius, A Bakhai, European Journal of Cardiovascular Prevention & Rehabilitation 11 (6), 460-465
• Clinical and Economic Outcomes of Percutaneous Coronary Interventions in the Elderly An Analysis of Medicare Claims Data, MA Clark, A Bakhai, MJ Lacey, EM Pelletier, DJ Cohen, Circulation 110 (3), 259-264
• Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service? S Palmer, M Sculpher, Z Philips, M Robinson, L Ginnelly, A Bakhai, International journal of cardiology 100 (2), 229-240
• The management and investigation of elderly patients with acute coronary syndromes without ST elevation: an evidence-based approach? Results of the Prospective Registry of Acute Ischaemic Syndromes in the United Kingdom (PRAIS-UK),J Collinson, A Bakhai, MD Flather, KA Fox, Age and ageing 34 (1), 61-66
• Diabetic patients with acute coronary syndromes in the UK: high risk and under treated. Results from the prospective registry of acute ischaemic syndromes in the UK (PRAIS-UK), A Bakhai, J Collinson, MD Flather, D Perez de Arenaza, MC Shibata, International journal of cardiology 100 (1), 79-84
• Cost-effectiveness of sirolimus drug-eluting stents for the treatment of complex coronary stenoses: results from the randomized SIRIUS trial, DJ Cohen, A Bakhai, C Shi, L Githiora, RH Berezin, RP Caputo, Journal of the American College of Cardiology 41 (6), 32
• A cost-effectiveness model comparing alternative management strategies for the use of glycoprotein IIb/IIIa antagonists in non-ST-elevation acute coronary syndrome, S Palmer, M Sculpher, Z Philips, M Robinson, L Ginnelly, A Bakhai, Technology Assessment Report. London: National Institute for Clinical ...
• Willingness to pay for avoiding coronary restenosis and repeat revascularization: results from a contingent valuation study, D Greenberg, A Bakhai, PJ Neumann, DJ Cohen, Health policy 70 (2), 207-216
• Cost-Effectiveness of Coronary Stenting and Abciximab for Patients With Acute Myocardial Infarction Results From the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial, A Bakhai, GW Stone, CL Grines, SA Murphy, L Githiora, RH Berezin, Circulation 108 (23), 2857-2863
• A cost-utility analysis of clopidogrel in patients with non-ST-segment-elevation acute coronary syndromes in the UK, J Karnon, A Bakhai, A Brennan, A Pandor, M Flather, E Warren, D Gray, International journal of cardiology 109 (3), 307-316
• Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future, MB Leon, A Bakhai, American heart journal 146 (4), S13-S17
• Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes, D PEREZ, MD ARENAZA, A BAKHAI, N Engl J Med 345 (21)
• Adipokines—targeting a root cause of cardiometabolic risk, A Bakhai, QJM 101 (10), 767-776
• Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling, M Robinson, S Palmer, M Sculpher, Z Philips, L Ginnelly, A Bowens, NIHR Evaluation, Trials and Studies Coordinating Centre (UK)
• Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis, Y Dündar, RA Hill, A Bakhai, R Dickson, T Walley, Scandinavian Cardiovascular Journal 38 (4), 200-210
• A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure, C McKenna, J Burch, S Suekarran, S Walker, A Bakhai, K Witte, M Harden, NIHR Evaluation, Trials and Studies Coordinating Centre (UK)
• Feasibility and cost of treatment with drug eluting stents of surgical candidates with multi-vessel coronary disease, H Griffiths, A Bakhai, D West, M Petrou, T De Souza, N Moat, J Pepper, European journal of cardio-thoracic surgery 26 (3), 528-534
• Age? 75 years is associated with greater resource utilization following coronary artery bypass grafting, I Toor, A Bakhai, B Keogh, M Curtis, J Yap, Interactive cardiovascular and thoracic surgery 9 (5), 827-831
• The SV stent study: a prospective, multicentre, angiographic evaluation of the BiodivYsio phosphorylcholine coated small vessel stent in small coronary vessels, A Bakhai, J Booth, N Delahunty, F Nugara, T Clayton, J McNeill, International journal of cardiology 102 (1), 95-102
• Modeling the impact of patient and lesion characteristics on the cost-effectiveness of drug-eluting stents, D Greenberg, A Bakhai, NE Neil, RH Berezin, KK Ho, DE Cutlip, RE Kuntz, Journal of the American College of Cardiology 41 (6), 538
• Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisal, EL Simpson, P Fitzgerald, P Evans, P Tappenden, N Kalita, JPD Reckless, Pharmacoeconomics 31 (4), 269-275
• The cost-effectiveness of the use of clopidogrel in acute coronary syndromes based upon the CURE study, A Lamy, S Chrolavicius, A Gafni, S Yusuf, F Zhao, B Jonsson, P Lindgren, Circulation 106 (19), 758-758
• Feasibility and implications of an early discharge strategy after percutaneous intervention with< i> abciximab in acute myocardial infarction (the CADILLAC Trial), DE Kandzari, JE Tcheng, DJ Cohen, A Bakhai, CL Grines, DA Cox, The American journal of cardiology 92 (7), 779-784
• Economic evaluation of drug-eluting stents: A systematic literature review and model-based cost–utility analysis, P Kuukasjärvi, P Räsänen, A Malmivaara, P Aronen, H Sintonen, International journal of technology assessment in health care 23 (04), 473-479
• Clinical outcomes, resource use, and costs at 1 year in patients with acute coronary syndrome undergoing PCI: results from the multinational APTOR registry, A Bakhai, J Ferrieres, A Iniguez, M Sartral, M Belger, C Schmitt, U Zeymer, Journal of interventional cardiology 25 (1), 19-27
• Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention, J Ferrieres, A Bakhai, A Iñiguez, C Schmitt, M Sartral, M Belger, U Zeymer, Current Medical Research & Opinion 26 (9), 2193-2202
• Clinical and economic effects of coronary restenosis after percutaneous coronary intervention in a managed care population. MA Clark, A Bakhai, EM Pelletier, DJ Cohen, Managed care (Langhorne, Pa.) 14 (4), 42-4, 46-51
• Differences in the use of guideline-recommended therapies among 14 European countries in patients with acute coronary syndromes undergoing PCI, U Zeymer, S James, G Berkenboom, A Mohacsi, A Iñiguez, Z Coufal, European journal of preventive cardiology 20 (2), 218-228
• Co?administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population, A Bakhai, U Rigney, S Hollis, C Emmas, Pharmacoepidemiology and drug safety 21 (5), 485-493
• Long term prognosis of heart failure after acute coronary syndromes without ST elevation, MC Shibata, J Collinson, AK Taneja, A Bakhai, MD Flather, Postgraduate medical journal 82 (963), 55-59
• Crossover trials, D Wang, U Lorch, A Bakhai, Clinical Trials—A Practical Guide to Design, Analysis, and Reporting ...
• The clinical and economic burden of restenosis in the Medicare population, M Clark, A Bakhai, M Lacey, E Pelletier, DJ Cohen, Circulation 106 (16), E102-E102
• Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis, RN Rodseth, BM Biccard, R Chu, GAL Buse, L Thabane, A Bakhai, Anesthesiology 119 (2), 270-283
• International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study, A Bakhai, J Ferrieres, A Iñiguez, C Schmitt, M Sartral, M Belger, U Zeymer, European Journal of Cardiovascular Prevention & Rehabilitation 18 (3), 518-525
• Remote monitoring after recent hospital discharge in patients with heart failure: a systematic review and network meta-analysis, A Pandor, T Gomersall, JW Stevens, J Wang, A Al-Mohammad, A Bakhai, Heart 99 (23), 1717-1726
• A cost-utility analysis of clopidogrel in patients with ST elevation acute coronary syndromes in the UK, J Karnon, MW Holmes, R Williams, A Bakhai, A Brennan, International journal of cardiology 140 (3), 315-322
• How to cost cardiovascular care, A Bakhai, Heart 94 (5), 549-551
• National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom, A Bakhai, MD Flather, J R Collinson, W Stevens, C Normand, E Alemao, International journal of cardiology 91 (2), 163-172
• Do the Benefits of New Technology Outweigh the Costs?: The Case of Drug-Eluting Stents, D Greenberg, A Bakhai, DJ Cohen, American Journal of Drug Delivery 1 (4), 255-266
• Trials comparing coronary artery bypass grafting with percutaneous transluminal coronary angioplasty and primary stent implantation in patients with multivessel coronary artery disease, A Bakhai, RH Stables, S Prasad, U Sigwart, Current opinion in cardiology 15 (6), 388-394
• Prasugrel vs clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a model-based cost-effectiveness analysis for Germany, Sweden, the Netherlands, and Turkey, A Davies, A Bakhai, C Schmitt, A Barrett, P Graham-Clarke, M Sculpher, Journal of medical economics 16 (4), 510-521
• Cost-effectiveness in France of fondaparinux versus enoxaparin in non-ST-elevation acute coronary syndrome: an analysis using data from OASIS-5, MJ Sculpher, G Lozano-Ortega, JC Sambrook, O Ormanidhi, A Bakhai, European Heart Journal 28, 858-858
• A primer for statistical analysis of clinical trials, D Wang, A Bakhai, N Maffulli, Arthroscopy: The Journal of Arthroscopic & Related Surgery 19 (8), 874-881
• Cost-Effectiveness of Aldosterone Antagonists for the Treatment of Post–Myocardial Infarction Heart Failure, C McKenna, S Walker, P Lorgelly, E Fenwick, J Burch, S Suekarran, Value in Health 15 (3), 420-428
• A meta-analysis of randomized controlled trials of intracoronary gamma-and beta-radiation therapy for in-stent restenosis, T Uchida, A Bakhai, A Almonacid, T Shibata, B Cox, RE Kuntz, Heart and vessels 21 (6), 368-374
• Admission ECG predicts long-term outcome in acute coronary syndromes without ST elevation, J Collinson, A Bakhai, A Taneja, D Wang, MD Flather, Qjm 99 (9), 601-607
• Analysis of survival data, D Wang, T Clayton, A Bakhai, Remedica
• Bioequivalence Trials, D Wang, R Arezina, A Bakhai, D Wang & A Bakhai,(Ed. s). Clinical trials: A practical guide to design ...
• How easy is it to contact the duty medical doctor responsible for acute admissions? A Bakhai, F Goodman, H Juchniewichz, A Martin, G Porter, C White, BMJ: British Medical Journal 301 (6751), 529